Robert H. Collins, Jr., M.D., F.A.C.P. is a Professor of Internal Medicine and Director of the Bone Marrow Transplant Program. He earned his M.D. degree from the six-year combined B.A./M.D. program at the University of Missouri-Kansas City. His internship and residency in Internal Medicine were completed at Baylor University Medical Center in Dallas and his fellowship in hematology/oncology at the University of California at Los Angeles. He is board certified in Internal Medicine and Medical Oncology. He has over 12 years experience in bone marrow transplantation and has participated in approximately 1,500 autologous and allogeneic transplants. Dr. Collins holds the R. Lloyd and Willye V. Skaggs Professorship in Medical Research and the Sydney and J.L. Huffines Distinguished Chair in Cancer Research in Honor of Eugene Frenkel, M.D. He is a Fellow of the American College of Physicians and is recognized by his peers in Best Doctors in America. He is a member of the American Association for the Advancement of Science, the American Society of Hematology, the American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. Dr. Collins is recognized as a leader in the field of adoptive immunotherapy and has directed studies of donor leukocyte infusions through an international network of over 100 centers. He is currently directing, in collaboration with the International Bone Marrow Transplant Registry, a multicenter trial of nonmyeloablative transplants in hematologic malignancies. He has published over 100 articles and abstracts in leading journals including New England Journal of Medicine, Blood, Journal of Clinical Oncology, and Annals of Internal Medicine. Dr. Collins is an active clinician, focusing on hematologic malignancies (leukemia, lymphoma, myeloma, Hodgkin’s disease, and myelodysplasia) and bone marrow transplantation. He instructs medical students, residents and fellows in these disciplines at UT Southwestern Medical School. Dr. Collins enjoys reading, music, outdoor activities and spending time with his wife and three sons.


Medical School
University of Missouri-Kansas City School of Medicine (1984)
Baylor University Medical Center (1987), Internal Medicine
UCLA (1989), Hematology Oncology

Research Interest

  • Adoptive immunotherapy
  • Immunology of allogeneic hematopoietic cell transplantations
  • Non-myeloablative stem cell transplantation


Featured Publications LegendFeatured Publications

Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation.
Levine JE, Braun T, Penza SL, eatty P, Cornetta K, Rodrigo M, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins Jr. RH. Journal of Clinical Oncology 2002 20 405-412
Contribution of the thymus to immune reconstitution following autologous hematopoietic stem cell transplant in adults.
Douek DC, Vescio RA, Betts MR, Brenchley JM, Zheng L, Berenson JR, Collins RH, Koup RA Lancet 2000 355 1875-81
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Collins RH, Shpilbert O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J. Journal of Clinical Oncology 1997 15 433-444

Honors & Awards

  • Fellow of the American College of Physicians
  • The Best Doctors in America
  • University of Missouri-Kansas Curator’s Scholarship for Academic Excellence
  • University of Missouri-Kansas Deans List for All Undergraduate Semesters
    St. Louis Friends of the UMKC School of Medicine Basic Science Award (0)
  • University of Missouri-Kansas Flarscheim Scholarship for Academic Excellence
    Recognition Award for Outstanding Achievement in the College of Arts and Sciences (0)